Skip to content
CompanySight
Company No. 16173765 · Incorporated 9 Jan 2025

Northern Pathology Developments Limited

Registered name: NORTHERN PATHOLOGY DEVELOPMENTS LIMITED

Part of The Christie Charity group

Northern Pathology Developments Limited made £0 revenue and £92k profit in the year to 31 Mar 2026.

Northern Pathology Developments Limited’s revenue was £0 in the year to 31 Mar 2026, with £92k profit. The company is classified under “development of building projects” and is based in Manchester.

Full P&L filedSection F · ConstructionSIC 41100Development of building projects
Status
Active
Location
Manchester, North West
Age
1 yr · since 2025
Type
Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2026

Key figures

Young and profitable
Revenue
£0
Growth —
Profit
£92k
Growth —
Profit margin
—
 
Employees
—
Change —
Profit / employee
—
 
Profitable streak
1yr
Consecutive profitable years in our data

Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

1 filed year

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 2026
DisclosureFull P&L
Profit & loss
Revenue (turnover)£0
Cost of sales£0
Gross profit£0
Operating profit−£12.1k
Profit before tax£92k
Profit after tax£92k
Profit (best available)£92k
Employees (average)—
Ratios
Profit margin—
Balance sheet — indirect signals, not revenue
Net assets—
SourceAccounts · bulk data Aug 2026
Derived from the latest filing

How the business works

Profit margin
—
Profit ÷ revenue.
Gross margin
—
Gross profit ÷ revenue. High for software and services.
Revenue per employee
—
Revenue ÷ average employees.
Profit per employee
—
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now —
Cash at bank
—
Now —
Headcount
—
Now —
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. The Christie Charityultimate parent75–100%
  2. Northern Pathology Developments Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (1)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from accounts for the year to 31 Mar 2026 (profit £92k), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Updated from Companies House on 13 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.